NO20051970L - Fremgangsmate for fremstilling av valsartan og mellomprodukter for fremgangsmaten samt fremstilling derav. - Google Patents

Fremgangsmate for fremstilling av valsartan og mellomprodukter for fremgangsmaten samt fremstilling derav.

Info

Publication number
NO20051970L
NO20051970L NO20051970A NO20051970A NO20051970L NO 20051970 L NO20051970 L NO 20051970L NO 20051970 A NO20051970 A NO 20051970A NO 20051970 A NO20051970 A NO 20051970A NO 20051970 L NO20051970 L NO 20051970L
Authority
NO
Norway
Prior art keywords
preparation
valsartan
intermediates
angiotensin
receptor antagonist
Prior art date
Application number
NO20051970A
Other languages
English (en)
Norwegian (no)
Inventor
Gottfried Sedelmeier
Daniel Kaufmann
Donatienne Denni-Dischert
Hans Hirt
Dan Neville
Anita Schnyder
Nadine Derrien
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9944606&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20051970(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20051970L publication Critical patent/NO20051970L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO20051970A 2002-09-23 2005-04-22 Fremgangsmate for fremstilling av valsartan og mellomprodukter for fremgangsmaten samt fremstilling derav. NO20051970L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0222056.4A GB0222056D0 (en) 2002-09-23 2002-09-23 Process for the manufacture of organic compounds
PCT/EP2003/010543 WO2004026847A1 (fr) 2002-09-23 2003-09-22 Procede de fabrication de valsartan

Publications (1)

Publication Number Publication Date
NO20051970L true NO20051970L (no) 2005-06-16

Family

ID=9944606

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20051970A NO20051970L (no) 2002-09-23 2005-04-22 Fremgangsmate for fremstilling av valsartan og mellomprodukter for fremgangsmaten samt fremstilling derav.
NO20110856A NO20110856L (no) 2002-09-23 2011-06-15 Fremgangsmate for fremstilling av valsartan

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20110856A NO20110856L (no) 2002-09-23 2011-06-15 Fremgangsmate for fremstilling av valsartan

Country Status (30)

Country Link
US (3) US20060069268A1 (fr)
EP (2) EP1878729A1 (fr)
JP (2) JP4787498B2 (fr)
KR (2) KR20110015703A (fr)
CN (2) CN100357279C (fr)
AR (1) AR041360A1 (fr)
AU (1) AU2003270241B2 (fr)
BR (1) BR0314132A (fr)
CA (1) CA2502629A1 (fr)
CY (1) CY1107878T1 (fr)
DE (1) DE60317690T2 (fr)
DK (1) DK1546122T3 (fr)
EC (2) ECSP055695A (fr)
ES (1) ES2295623T3 (fr)
GB (1) GB0222056D0 (fr)
HK (1) HK1079771A1 (fr)
IL (1) IL167426A (fr)
MX (1) MXPA05003140A (fr)
MY (1) MY138618A (fr)
NO (2) NO20051970L (fr)
NZ (2) NZ566863A (fr)
PE (2) PE20091387A1 (fr)
PL (1) PL374862A1 (fr)
PT (1) PT1546122E (fr)
RU (2) RU2412173C2 (fr)
SG (1) SG155049A1 (fr)
SI (1) SI1546122T1 (fr)
TW (2) TWI329106B (fr)
WO (1) WO2004026847A1 (fr)
ZA (1) ZA200502159B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7199144B2 (en) 2003-04-21 2007-04-03 Teva Pharmaceuticals Industries, Ltd. Process for the preparation of valsartan and intermediates thereof
DE602004013405T2 (de) * 2003-03-17 2009-05-07 Teva Pharmaceutical Industries Ltd. Polymorphe formen von valsartan
WO2004094392A1 (fr) 2003-04-21 2004-11-04 Teva Pharmaceutical Industries Ltd. Processus de preparation de valsartan
WO2004094391A2 (fr) * 2003-04-21 2004-11-04 Teva Pharmaceutical Industries Ltd. Procede de preparation du valsartan et de ses intermediaires
GB0316546D0 (en) * 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
GB0402262D0 (en) * 2004-02-02 2004-03-10 Novartis Ag Process for the manufacture of organic compounds
EP1661891A1 (fr) * 2004-11-30 2006-05-31 KRKA, D.D., Novo Mesto Procédé de prépartion de valsartan
GB0514206D0 (en) 2005-07-11 2005-08-17 Novartis Ag Organic compounds
ES2288376B1 (es) * 2005-10-20 2008-11-01 Inke, S.A. Procedimiento para la obtencion de intermedios utiles en la obtencion de un compuesto farmaceuticamente activo.
WO2007057919A2 (fr) * 2005-10-25 2007-05-24 Alembic Limited Procede ameliore pour la preparation de (s)-n-(1-carboxy-2-methyl-prop-1-yl)-n-pentanoyl-n-[2'-(1h-tetrazol-5-yl)biphenyl-4-ylmethyl]-amine
US7880015B2 (en) * 2006-07-03 2011-02-01 Aurobindo Pharma Ltd. Process for the preparation of angiotensin II antagonist
ES2315141B1 (es) * 2006-11-23 2009-12-22 Quimica Sintetica, S.A Procedimiento para la preparacion de cardesartan cilexetilo en forma cristalina.
CN101200455B (zh) * 2007-09-29 2010-08-18 泰兴市江神化工有限公司 沙坦类治疗高血压药物主环5-(4'-甲酰基联苯-2-基)-1h-四氮唑的制备方法
EP2090567A3 (fr) 2008-02-13 2011-06-01 Ranbaxy Laboratories Limited Processus pour la préparation d'intermédiaires de valsartan
KR101012135B1 (ko) * 2008-12-18 2011-02-07 주식회사 대희화학 발사르탄 메틸 에스테르의 제조방법
EP2316821A1 (fr) 2009-10-27 2011-05-04 Novartis AG Procédé pour la fabrication de composés organiques
KR20130139863A (ko) * 2010-08-03 2013-12-23 노파르티스 아게 고도 결정질 발사르탄
CN102351804B (zh) * 2011-09-30 2013-07-31 浙江新赛科药业有限公司 一种缬沙坦消旋体的回收方法
CN103554047A (zh) * 2013-10-11 2014-02-05 镇江市高等专科学校 制备缬沙坦的方法
CN103923028B (zh) * 2014-05-04 2017-05-24 青岛雪洁助剂有限公司 一种缬沙坦甲酯的制备方法
CN104072433A (zh) * 2014-07-16 2014-10-01 南京正大天晴制药有限公司 一种缬沙坦的水解杂质化合物及其制备方法、检测方法和用途
CN104151199A (zh) * 2014-08-13 2014-11-19 苏州卫生职业技术学院 一种缬沙坦的合成方法
CN104844476B (zh) * 2015-04-03 2016-08-24 李凌 一种医药中间体联苯类化合物的合成方法
CN112014479A (zh) * 2019-05-28 2020-12-01 珠海润都制药股份有限公司 一种缬沙坦中正戊酰氯的检测方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0443983T3 (da) * 1990-02-19 1996-03-18 Ciba Geigy Ag Acrylforbindelser
US5260325A (en) * 1991-08-19 1993-11-09 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking tertiary amides
EP0550313A1 (fr) * 1991-12-30 1993-07-07 Synthelabo Nouveaux dérivés de 2-(tétrazol-5-yl)-(1,1'-biphényle), leur préparation et leur utilisation comme intermédiaires de synthèse
FR2688503B1 (fr) * 1992-03-16 1994-05-06 Synthelabo Procede de preparation de derives de 2-(tetrazol-5-yl)-[1,1'-biphenyle].
US5284957A (en) * 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
JPH08165292A (ja) * 1993-10-07 1996-06-25 Techno Res Kk アデニン誘導体、その製造法及び用途
US5468867A (en) * 1994-05-27 1995-11-21 Syntex (U.S.A.) Inc. Process for preparing1-butyl-2-[2'-(2H-tetrazol-5-yl)biphenyl-4-ylmethyl1-1H-indole-3-carboxylic acid
US5412102A (en) * 1994-05-27 1995-05-02 Syntex (U.S.A.) Inc. Processes for preparing 1-butyl-2-[2'-(2H-tetrazol-5-yl) biphenyl-4-ylmethyl]-1H-indole-3-carboxylic acid
US5965738A (en) * 1994-09-20 1999-10-12 Wakunaga Seiyaku Kabushiki Kaisha Process for producing N-biphenylmethylthiadiazoline derivative or salt thereof and intermediate for producing the same
JPH11507625A (ja) * 1995-06-07 1999-07-06 アメリカン・ホーム・プロダクツ・コーポレイション ビフェニル誘導体の製造方法
CN1137887C (zh) * 2000-04-07 2004-02-11 常州四药制药有限公司 一种合成缬沙坦的改进方法
PL205715B1 (pl) * 2000-07-19 2010-05-31 Novartis Ag Sól wapniowa walsartanu w postaci tetrahydratu, preparat farmaceutyczny zawierający tę sól, zastosowanie i sposób wytwarzania tej soli
GB0402262D0 (en) * 2004-02-02 2004-03-10 Novartis Ag Process for the manufacture of organic compounds

Also Published As

Publication number Publication date
KR20050057529A (ko) 2005-06-16
CA2502629A1 (fr) 2004-04-01
DK1546122T3 (da) 2008-03-03
US20060069268A1 (en) 2006-03-30
JP2006502178A (ja) 2006-01-19
PE20091387A1 (es) 2009-10-13
CN1688556A (zh) 2005-10-26
CN100357279C (zh) 2007-12-26
CY1107878T1 (el) 2013-06-19
ECSP055695A (es) 2005-05-30
AU2003270241A1 (en) 2004-04-08
EP1546122B8 (fr) 2008-05-28
RU2008133680A (ru) 2010-02-27
CN101153027B (zh) 2010-08-18
ES2295623T3 (es) 2008-04-16
PE20050088A1 (es) 2005-02-21
NZ566863A (en) 2009-08-28
MXPA05003140A (es) 2005-06-22
DE60317690T2 (de) 2008-10-30
US20100249429A1 (en) 2010-09-30
JP4787498B2 (ja) 2011-10-05
MY138618A (en) 2009-07-31
RU2412173C2 (ru) 2011-02-20
AR041360A1 (es) 2005-05-11
SG155049A1 (en) 2009-09-30
BR0314132A (pt) 2005-06-28
IL167426A (en) 2010-11-30
CN101153027A (zh) 2008-04-02
PT1546122E (pt) 2008-02-14
GB0222056D0 (en) 2002-10-30
DE60317690D1 (de) 2008-01-03
PL374862A1 (en) 2005-11-14
RU2005112444A (ru) 2006-01-20
TWI329106B (en) 2010-08-21
EP1878729A1 (fr) 2008-01-16
RU2348619C2 (ru) 2009-03-10
AU2003270241B2 (en) 2007-08-23
NZ538927A (en) 2008-05-30
JP2010254709A (ja) 2010-11-11
US20090111995A1 (en) 2009-04-30
ZA200502159B (en) 2005-09-21
KR20110015703A (ko) 2011-02-16
SI1546122T1 (sl) 2008-04-30
WO2004026847A1 (fr) 2004-04-01
ECSP105695A (es) 2010-03-31
EP1546122B1 (fr) 2007-11-21
TW201016673A (en) 2010-05-01
TW200413337A (en) 2004-08-01
TWI338003B (en) 2011-03-01
NO20110856L (no) 2005-06-16
EP1546122A1 (fr) 2005-06-29
HK1079771A1 (en) 2006-04-13

Similar Documents

Publication Publication Date Title
NO20051970L (no) Fremgangsmate for fremstilling av valsartan og mellomprodukter for fremgangsmaten samt fremstilling derav.
NO20050429L (no) Substituert kinolin-CCR5-reseptorantagonister
MY141559A (en) Triazole derivatives as tachykinin receptor antagonists
DE60217147D1 (de) Lactamderivaten zur verwendung als humane 11cby rezeptorantagonisten
MXPA04010625A (es) Antagonista de receptor de taquicinina.
TNSN05105A1 (en) Novel bicyclic inhibitors of hormone sensitive lipase
GEP20084494B (en) New heterocyclic carboxylic acid amide derivatives
NO20060184L (no) Fremgangsmate for fremstilling av ikke-peptid substituerte spirobenzoazepinderivater
NO20055752L (no) N-ureidoalkyl-piperidiner som modulerer forbindelser av kjemokinreseptor-aktivitet
TNSN07015A1 (en) Kynurenic acid amide derivatives as nr2b receptor antagonists
AU2003274307A1 (en) 5-ht 1b/1d receptor agonists for the treatment of headache resulting from administering an endothelin receptor antagonist
NO20040388L (no) Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten
EA200200101A1 (ru) Получение замещенных пиперидин-4-онов
MY138550A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
MY139159A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
NO20053208L (no) Metode for reduktiv dehalogenering.
MY139348A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
EP1579212A4 (fr) Methodes d'identification d'agonistes du recepteur transmembranaire a internalisation reduite
NO980906L (no) Nye, antikonvulsivt virkende 1-ar(alk)yl-imidazolin-2-oner, som i 4-stilling inneholder en disubstituert aminrest og en fremgangsmåte for deres fremstilling
NO20060922L (no) Ny fremgangsmate for syntesen av perindopril og dens farmasoytiske akseptable salter
PL374961A1 (en) Process for preparing intermediates
EP1619499A4 (fr) Nouvelle methode de criblage
FR2845916B1 (fr) Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l'histamine
WO2003082320A1 (fr) Nouveau procede de criblage
AU2003274087A1 (en) Method for identifying agonists or antagonists for the gpr45-like/gpr63 receptor

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application